Kenney Christopher John
Officer at XENE
- Sold, on record
- $695k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 28, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XENEXenon Pharmaceuticals Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale XENEUnusualMar 24, 2023 2023
Sold 700 shares at $35.01 ($25k)
Kenney Christopher John, Chief Medical Officer
No 10b5-1 planSold 100% of holdings ($25k position)0 shares leftFirst sale on recordFiling
- 2 Form 144 notice XENENoticeMar 10, 2026 +1082 days
Filed to sell 2,771 shares ($167k)
Kenney Christopher John, Officer
10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale XENERoutineMar 10, 2026 same day
Sold 2,771 shares at $60.11 ($167k)
Kenney Christopher John, Chief Medical Officer
10b5-1 planSold 36.9% of holdings ($451k position)4,729 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale XENERoutineMar 13, 2026 +3 days
Sold 1,410 shares at $55.23 ($78k)
Kenney Christopher John, Chief Medical Officer
10b5-1 planSold 16.6% of holdings ($468k position)7,069 shares leftFollows a Form 144Filing
- 5 Form 144 notice XENENoticeMar 13, 2026 same day
Filed to sell 1,410 shares ($78k)
Kenney Christopher John, Officer
10b5-1 planFiling
- 6 Form 144 notice XENENoticeAug 28, 2026 +168 days
Filed to sell 7,068 shares ($438k)
Kenney Christopher John, Officer
10b5-1 planFiling
- 7 Form 4 sale XENERoutineAug 28, 2026 same day
Sold 7,068 shares at $60.25 ($426k)
Kenney Christopher John, Chief Medical Officer
10b5-1 planSold 100% of holdings ($426k position)2 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Aug 31, 2026 | XENE | Chief Medical Officer | Form 4 sale | 7,068 | $426k | 100.0% | Routine | SEC |
| Aug 28, 2026 | Aug 28, 2026 | XENE | Officer | Form 144 notice | 7,068 | $438k | Notice | SEC | |
| Mar 13, 2026 | Mar 13, 2026 | XENE | Officer | Form 144 notice | 1,410 | $78k | Notice | SEC | |
| Mar 13, 2026 | Mar 13, 2026 | XENE | Chief Medical Officer | Form 4 sale | 1,410 | $78k | 16.6% | Routine | SEC |
| Mar 10, 2026 | Mar 11, 2026 | XENE | Chief Medical Officer | Form 4 sale | 2,771 | $167k | 36.9% | Routine | SEC |
| Mar 10, 2026 | Mar 10, 2026 | XENE | Officer | Form 144 notice | 2,771 | $167k | Notice | SEC | |
| Mar 24, 2023 | Mar 24, 2023 | XENE | Chief Medical Officer | Form 4 sale | 700 | $25k | 100.0% | Unusual | SEC |